Skip to main content

Select Accept all cookies to allow optional cookies, or Reject optional cookies to turn off optional advertising cookies. Analytics remains on with either choice. You can change your advertising choice at any time through Cookie settings.

Cookie Policy (opens in a new tab)Privacy Policy (opens in a new tab)

Global Markets

Primagrove IPO: Small Earnings, Large Valuation Test

Revenue expanded sharply in 2025, but the post-offer valuation assumes a much larger and steadier business than the filing has yet demonstrated · Serrari IPO Watch · Research cut-off 9 November 2026

Published 9 November 202610 min readSerrari Compliance & Strategy
Contents & display options
Global Markets

Primagrove IPO: Small Earnings, Large Valuation Test

Revenue expanded sharply in 2025, but the post-offer valuation assumes a much larger and steadier business than the filing has yet demonstrated · Serrari IPO Watch · Research cut-off 9 November 2026

Published 9 November 202610 min readSerrari Compliance & Strategy

Primagrove Limited’s September F-1 proposes 6.25m new ordinary shares at $4–$6 for a Nasdaq listing under YHTE (calendars show YNTE — unresolved). FY2025 revenue was $1.83m with $1.07m net income, yet the $5 midpoint implies a $131.25m equity value: ~71.6x sales and ~122.7x earnings for a Hong Kong project-based technology-services firm.

Primagrove IPO: Small Earnings, Large Valuation Test

Report cover: Primagrove IPO — $1.83m FY2025 reported revenue, $131.25m value at $5 midpoint, YHTE ticker in the SEC filing
Report cover: Primagrove IPO — $1.83m FY2025 reported revenue, $131.25m value at $5 midpoint, YHTE ticker in the SEC filing

SERRARI GROUP / ANALYST DESK — HONG KONG TECHNOLOGY SERVICES | PROPOSED IPO

Revenue expanded sharply in 2025, but the post-offer valuation assumes a much larger and steadier business than the filing has yet demonstrated.

$1.83m — FY2025 reported revenue

$131.25m — Value at $5 midpoint

YHTE — Ticker in the SEC filing

IPO calendar shows YNTE: conflicts with YHTE in Form F-1 | Target week 16 Nov is indicative

RESEARCH CUT-OFF: 09 NOVEMBER 2026 | SCENARIOS ARE ILLUSTRATIVE


Executive take

Executive take: proposed capital raise, business quality question, financial contrast, critical publication correction
Executive take: proposed capital raise, business quality question, financial contrast, critical publication correction

A strong 2025 profit margin does not alone justify the midpoint implied equity valuation. [F1–F3]

Proposed capital raise

The September F-1 describes 6.25 million new ordinary shares at $4–$6 each, implying $25m–$37.5m gross and $31.25m at the midpoint. No offering or Nasdaq listing is completed in this preliminary filing.

Business quality question

Hong Kong subsidiary Oceanic Bounty generates custom software, website development and tech-enabled workspace revenues. Much of the work is project-based rather than proven multi-year recurring subscription income.

Financial contrast

FY2025 revenue rose to $1.834m from $98,227 in 2024; net income reached $1.070m. The company disclosed only $17,015 of year-end cash following significant financing outflows and dividends.

Critical publication correction

The SEC prospectus proposes symbol YHTE while secondary calendars show YNTE. The final ticker, pricing and Nasdaq approval must be verified before publishing any statement of confirmed listing terms.


Offering structure and what is confirmed

Offering structure: issuer and operating location, security and exchange, post-offering ownership, ticker conflict
Offering structure: issuer and operating location, security and exchange, post-offering ownership, ticker conflict

The 16 November week is a calendar expectation; issuer documents do not promise a trading date. [F1–F3]

Issuer and operating location

Primagrove Limited is incorporated in the Cayman Islands and conducts its business through Hong Kong operating subsidiary Oceanic Bounty Limited. IPO investors buy holding-company ordinary shares.

Security and exchange

The F-1 proposes ordinary shares on the Nasdaq Capital Market at $4–$6. It states that approval has not yet been granted and closing is conditioned on final Nasdaq listing approval.

Post-offering ownership

20 million ordinary shares are outstanding before the deal; 26.25 million would be outstanding after the 6.25 million share offering without the 937,500-share over-allotment option.

Ticker conflict

The 30 September F-1 explicitly uses YHTE. External calendars label the same issuer YNTE. This is unresolved in the reviewed record: do not silently use the calendar symbol as final.


Operating segments: what the firm actually sells

Operating segments: systems development, website design, workspace products, investment moat
Operating segments: systems development, website design, workspace products, investment moat

The portfolio is technology services plus embedded software hardware, not an AI infrastructure company. [F1]

Systems development

Custom applications, workflow automation, databases, business processes, deployment and maintenance. Revenue is typically recognised as contracted projects are delivered.

Website design

Customer-facing website design and digital development services. Project size and delivery timing can make revenue lumpy compared with recurring hosted software subscriptions.

Workspace products

Smart workplace solutions containing embedded software, including lockers and booths. This line first contributed material revenue in FY2025, but introduces product fulfilment and supply dependence.

Investment moat

Execution track record, local relationships and delivery expertise matter. The filing says it has no dedicated R&D function, limiting evidence for a proprietary-platform or unique-technology premium.


Income statement: one-year scale change

Bar chart — FY2024 vs FY2025 financials (US$m): 2024 sales 0.10, 2025 sales 1.83, 2024 profit 0.02, 2025 profit 1.07
Bar chart — FY2024 vs FY2025 financials (US$m): 2024 sales 0.10, 2025 sales 1.83, 2024 profit 0.02, 2025 profit 1.07

The reporting base is small, so percentage growth alone can be misleading. [F1]

FY2024 vs FY2025 financials (US$m)

2024 sales: 0.10 · 2025 sales: 1.83 · 2024 profit: 0.02 · 2025 profit: 1.07

Operating leverage

FY2025 gross profit was $1.368m versus $0.080m in FY2024. General and administrative expense increased to just $112,861, producing an unusually high 58.3% net margin in 2025.

Quality of growth

Revenue rose around 1,767%, largely through larger and more projects, including a new workspace category. The small FY2024 base exaggerates the usefulness of percentage growth as a forward guide.

All numbers are audited FY financials reported in the preliminary F-1; not a forecast or run-rate.


Cash conversion, working capital and distributions

Cash conversion: cash flow generated, why cash remained small, dividends and ownership, balance-sheet reading
Cash conversion: cash flow generated, why cash remained small, dividends and ownership, balance-sheet reading

Profit reported in the income statement does not equal cash retained at the end of the year. [F1]

Cash flow generated

FY2025 net cash from operations was approximately $1.382m, compared with $38,316 in FY2024. The reported operating cash inflow therefore exceeds accounting net income.

Why cash remained small

Year-end cash was $17,015 versus $34,469 the prior year after net investing outflow of $101,103 and financing outflow of $1.298m. Annual cash stocks reflect uses beyond operations.

Dividends and ownership

The statement of changes in equity shows $897,436 of declared and paid dividends in FY2025. Assess how distributions before a major primary raise affect the capital-need narrative.

Balance-sheet reading

Working capital was $103,504 at FY2025 year end, up from $5,807. Related-party balances, receivables and contract liabilities deserve examination before extrapolating reported profit into free cash flow.


IPO valuation: the price-to-fundamentals gap

Bar chart — implied post-offer equity value (US$m): $4 low 105, $5 mid 131, $6 high 158
Bar chart — implied post-offer equity value (US$m): $4 low 105, $5 mid 131, $6 high 158

At midpoint, the proposed share count implies a valuation many times the FY2025 turnover. [F1]

Implied post-offer equity value (US$m)

$4 low: 105 · $5 mid: 131 · $6 high: 158

At the $5 midpoint

26.25 million post-offer shares times $5 implies $131.25 million equity market value. That is approximately 71.6 times reported FY2025 revenue.

Earnings comparison

The same equity value equals roughly 122.7 times FY2025 net income. These are retrospective illustrative multiples, not fair-value estimates or normalised forecasts.

Range assumes 26.25m post-offer shares before underwriter exercise; does not imply these prices will trade.


Ownership and net-tangible-value dilution

Ownership and dilution: new share of equity, controlling shareholder, book-value dilution, why it matters
Ownership and dilution: new share of equity, controlling shareholder, book-value dilution, why it matters

The issuer’s disclosed dilution is much larger than the conventional ownership shift. [F1]

New share of equity

6.25 million newly issued shares represent about 23.8% of 26.25 million base post-offer shares. Existing shareholders retain approximately 76.2%.

Controlling shareholder

The F-1 says Aurora Grove’s ownership would decline from 75.1% to approximately 57.2%, leaving it a majority holder after the base offering.

Book-value dilution

The prospectus illustrates post-IPO net tangible book value of approximately $1.06 per share at a $5 offering price, implying immediate tangible-book-value dilution of about $3.94 per IPO share.

Why it matters

A new investor can pay a substantial premium above current tangible value for anticipated growth. But governance concentration and weak secondary liquidity may amplify downside when execution disappoints.


Allocation of IPO proceeds

Bar chart — proposed net proceeds allocation (%): workforce 30%, technology 25%, workspace 20%, sales 15%, other 10%
Bar chart — proposed net proceeds allocation (%): workforce 30%, technology 25%, workspace 20%, sales 15%, other 10%

Management proposes to invest far more than the annual revenue base; returns will depend on execution. [F1]

Proposed net proceeds allocation (%)

Workforce: 30% · Technology: 25% · Workspace: 20% · Sales: 15% · Other: 10%

Human capital and technology

55% of net funds target new technical employees, delivery capacity and technology systems. This may widen addressable workload, but raises fixed overhead before a reliable pipeline is proved.

Growth expenditures

20% targets workspace products, 15% sales and market entry and 10% acquisitions/working capital. The F-1 indicates net proceeds around $27.6m at midpoint, but it is still preliminary.

Percentages are management intentions, not committed contracts or demonstrated returns on invested capital.


Risk map: price premium versus execution evidence

Risk map table: valuation compression and customer turnover high/high; supplier concentration and post-raise spending high/medium; controlling ownership medium/high; IPO approval/symbol medium/medium
Risk map table: valuation compression and customer turnover high/high; supplier concentration and post-raise spending high/medium; controlling ownership medium/high; IPO approval/symbol medium/medium
RiskAssessmentTransmissionWhy it matters
Valuation compressionHigh / HighMultiples fall~71.6x sales requires sustained growth beyond FY2025.
Customer turnoverHigh / HighRevenue volatilityNo 2024 major client remained major in 2025.
Supplier concentrationHigh / MediumDelivery costsTop three 2025 suppliers = 51.6% of costs.
Controlling ownershipMedium / HighGovernanceMajority shareholder retains material voting power.
IPO approval / symbolMedium / MediumTiming and accuracyNasdaq approval and final YHTE/YNTE symbol unresolved.
Post-raise spendingHigh / MediumMargin declineHiring and expansion may reverse current small-overhead profits.

Company-specific operational risks and offer mechanics should drive diligence.

Figure: Risk map — price premium versus execution evidence.


How growth capital could help or hurt equity returns

Transmission chain 01 raise, 02 pipeline, 03 delivery, 04 return; positive case and negative case
Transmission chain 01 raise, 02 pipeline, 03 delivery, 04 return; positive case and negative case

Project acquisition, staffing and revenue recognition form the central transmission chain.

01 RAISE — New capital supports hires, systems, products and sales.

→ 02 PIPELINE — Management must win larger contracts at acceptable terms.

→ 03 DELIVERY — Projects require suppliers, staff and milestone completion.

→ 04 RETURN — Repeat customer value and cash retention determine durable earnings.

Positive case

Expansion creates repeat business with strong cash collection and more efficient delivery. The company retains profitability while reducing dependency on irregular one-off contracts.

Negative case

Headcount, compliance and product spending rise before repeat orders materialise. Margins normalise sharply; the high implied equity multiple compresses even if revenue keeps growing.


Scenario map: growth must close the valuation gap

Scenario map: upside repeatable growth, central project volatility, downside contraction
Scenario map: upside repeatable growth, central project volatility, downside contraction

Illustrations concern operational direction, not numerical price predictions.

Upside: repeatable growth

Management converts the exceptional FY2025 expansion into sustained multi-year contracts, maintains strong collections and scales without a proportional overhead increase. The business earns a greater technology-services premium.

Central: project volatility

Contracts continue but remain lumpy. Hiring raises costs and profit margins normalise from unusually high FY2025 levels. Investors re-evaluate a valuation anchored to limited historical earnings.

Downside: contraction

Large-client churn, supplier cost inflation or slower projects reduce revenue quality. A controlling shareholder and limited float complicate price discovery; the valuation premium erodes.

Scenarios describe conditional paths, not probability-weighted price targets or investment recommendations.


What to verify before an IPO assessment goes live

Verification checklist: ticker reconciliation, new financial period, effective float and controls, sustainable valuation
Verification checklist: ticker reconciliation, new financial period, effective float and controls, sustainable valuation

A publication-ready analyst view requires reconciliation of identity, pricing and fresh financials. [F1–F3]

1. Ticker reconciliation

Compare a newer issuer amendment, Nasdaq listing notice and final 424B4 prospectus. YHTE in September F-1 conflicts with YNTE on the cited calendar.

2. New financial period

Request 2026 interim revenue, gross profit, customer concentration, receivable ageing and new-project backlog before modelling 2025 growth as a reliable run-rate.

3. Effective float and controls

Check 180-day lock-ups, 937,500-share overallotment, post-offer beneficial ownership and any governance protections for outside shareholders.

4. Sustainable valuation

Sensitivity-test annual revenue and gross margin after hiring, compare peer values at similar scale, and use cash-based earnings rather than extrapolating one year of high net margins.


Investment assessment: the growth burden is heavy

Investment assessment: ~71.6x FY2025 price-to-sales at midpoint, ~122.7x FY2025 price-to-earnings at midpoint, $17,015 FY2025 year-end reported cash; Serrari Analyst Desk conclusion
Investment assessment: ~71.6x FY2025 price-to-sales at midpoint, ~122.7x FY2025 price-to-earnings at midpoint, $17,015 FY2025 year-end reported cash; Serrari Analyst Desk conclusion

The prospectus establishes genuine profits; the headline midpoint price demands much stronger evidence of durability.

~71.6x — FY2025 price-to-sales at midpoint

~122.7x — FY2025 price-to-earnings at midpoint

$17,015 — FY2025 year-end reported cash

Serrari Analyst Desk conclusion

Primagrove has reported dramatic revenue growth and positive 2025 earnings, but the preliminary $5 midpoint implies a $131.25m equity value for a $1.83m-revenue project-based business. Customer turnover, supplier concentration, majority control and elevated expected spending challenge the sustainability of that premium. A genuine red flag for publication is the YHTE-versus-YNTE ticker mismatch. Assessment: substantial valuation and execution risk until a final filing, 2026 trading evidence and recurring-contract quality demonstrate that the earnings can scale.


Sources, method and release checks

Evidence register F1 to F3, methodology and interpretation, investment-risk notice and publication QA
Evidence register F1 to F3, methodology and interpretation, investment-risk notice and publication QA

SERRARI GROUP | ANALYST DESK | 09 NOVEMBER 2026

Evidence register

F1 — Primagrove Form F-1, 30 September 2026 — Business, filed YHTE ticker, terms, annual financial statements and major risks.

F2 — IPOScoop IPO calendar — Indicative 16 November window and discrepant proposed YNTE ticker.

F3 — IPOScoop recently filed register — Price range, offer count, and calendar cross-check.

Methodology and interpretation

The SEC Form F-1 dated 30 September 2026 is preliminary; a completed Nasdaq listing or definitive 16 November date was not verified. The registered proposed symbol is YHTE, in contrast to YNTE on certain market calendars. Gross fundraising is 6.25m × $4/$5/$6. Post-IPO share count is 26.25m, implying equity value of $105m/$131.25m/$157.5m. At midpoint, P/S = $131.25m/$1.833666m = ~71.6x and P/E = $131.25m/$1.069698m = ~122.7x using FY2025, not forecasts. Ratios exclude full option exercise and assume no material other dilution. The $17,015 cash figure is a 2025 year-end point-in-time balance and cannot independently establish operational solvency.

Investment-risk notice

For financial research, market education and decision support only. Not an offer, solicitation, personalised investment recommendation or assurance of listing. Preliminary prospectus terms may change. Underwriting, warrants, contingencies, taxes and subsequent capital actions may alter implied values and ownership. Perform independent due diligence and consult the final prospectus before investing.

Publication QA

Figures checked against issuer filings as cited; market calendars are indicative; SEC documents do not establish an exchange trading date until the relevant conditions are fulfilled. All analyst sensitivity calculations are identified as illustrative.